Vigilant Capital Management, LLC United Therapeutics Corp Transaction History
Vigilant Capital Management, LLC
- $1.34 Billion
- Q2 2023
A detailed history of Vigilant Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 639 shares of UTHR stock, worth $202,492. This represents 0.01% of its overall portfolio holdings.
Number of Shares
639
Previous 639
-0.0%
Holding current value
$202,492
Previous $143,000
1.4%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
562Shares Held
43.1MCall Options Held
501KPut Options Held
529K-
Black Rock Inc. New York, NY5.57MShares$1.76 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$1.48 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.41MShares$1.08 Billion0.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$906 Million7.91% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$682 Million0.78% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...